TIMP2 and breast cancer: There are several pathways involving MMP-2 that are studied for future therapeutics in BC, including (1) TIMP2-MMP-2/-9 pathway, (2) PI3K/AKT signaling pathway, (3) elevated STAT3 signaling, and (4) inhibiting RhoA pathway in TNBC.